Reich, Kristian, Mark Lebwohl, Carle Paul, Mads Ropke, Monika Rosen, and Klaus Hansen. 2018. “Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients With Moderate-to-Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine 2 (S1):S1. https://doi.org/10.25251/skin.2.supp.1.